Published in Obesity and Diabetes Week, October 9th, 2006
Study 1: Angiotensin converting enzyme (ACE)-related carboxypeptidase expression is increased at the post-transcriptional level in the renal cortex of diabetic mice.
"ACE-related carboxypeptidase (ACE2) may counterbalance the angiotensin (ANG) II-promoting effects of ACE in tissues where both enzymes are found. Alterations in renal ACE and ACE2 expression have been described in experimental models of diabetes, but ACE2 activity was not assessed in previous studies," scientists in the United States report.
J. Wysocki and colleagues at Northwestern...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.